AbCellera Biologics stock is trading inside a triangle pattern and testing the key support at 3.90–4.00.
Signals are showing that sellers are losing momentum: CCI prints a bullish divergence and the volume profile highlights accumulation above the current level. A breakout above the descending trendline around 4.30 could open the way towards 4.80 and even 5.60.
From a fundamental perspective the company remains an important biotech player focusing on antibody-based drug development. The sector is highly news driven and any announcement on trials or partnerships could trigger sharp moves.
As long as support holds buyers keep the advantage and the market looks like a spring that has been compressed too long and is ready to release.
Signals are showing that sellers are losing momentum: CCI prints a bullish divergence and the volume profile highlights accumulation above the current level. A breakout above the descending trendline around 4.30 could open the way towards 4.80 and even 5.60.
From a fundamental perspective the company remains an important biotech player focusing on antibody-based drug development. The sector is highly news driven and any announcement on trials or partnerships could trigger sharp moves.
As long as support holds buyers keep the advantage and the market looks like a spring that has been compressed too long and is ready to release.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.